Citius Pharmaceuticals, Inc. (CTXR) stock
CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
$0.52−0.01 (-1.67%)
Close on Nov 17, 2026Market cap $14.24MP/E –Yield –
Citius Pharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Citius Pharmaceuticals's price to sales ratio was 379.3× on Jan 31, 2020.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2020 | Jan 31, 2020 | 379.3× | +51.4 |
| 2019 | Dec 31, 2019 | 327.9× | +103.3 |
| 2018 | Dec 31, 2018 | 224.6× | – |
See a number that looks wrong?